Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Pacira Pharmaceuticals Inc
PCRX | US
22.11
USD-0.46
-2.04%
PCRX | US
About Pacira Pharmaceuticals Inc
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
20/03/2026
Close
22.11
Open
22.75
High
22.78
Low
21.84
Pacira BioSciences Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL a bupivacaine liposome injectable suspension; ZILRETTA a triamcinolone acetonide extended-release injectable suspension; and iovera system a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals Inc. and changed its name to Pacira BioSciences Inc. in April 2019. Pacira BioSciences Inc. was incorporated in 2006 and is headquartered in Tampa Florida.
View LessPCRX | US
Risk
36.9
Sharpe
-0.33
Luna's Score
30/100
Recommendation
Sell
Luna says (PCRX | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Current Volume and Negative 1-Day Return
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
37.7%1 month
36.9%3 months
46.9%6 months
40.9%Returns
Fundamental Ratios
PE
13.05
Fwd. PE
4.51
Price to book
0.92
Debt to equity
0.74
Debt to assets
0.39
Ent. to EBITDA
5.65
Ent. to rev.
1.52
PEG
-3.83
Other Fundamentals
EBITDA
175.34M
MarketCap
1.02B
MarketCap(USD)
1.02B
Div. yield
-
Op. margin
17.40
Erngs. growth
-24.50
Rev. growth
5.00
Ret. on equity
7.54
Short ratio
5.45
Short perc.
19.93
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.94
Range1M
3.48
Range3M
8.19
Volumes: Market Activity
Rel. volume
2.21
Price X volume
47.06M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 5.65 | - | Cheaper |
| Ent. to Revenue | 1.52 | - | Cheaper |
| PE Ratio | 13.05 | 30.05 | Cheaper |
| Price to Book | 0.92 | 13.15 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 46.88 | - | Lower Risk |
| Debt to Equity | 0.74 | -1.88 | Expensive |
| Debt to Assets | 0.39 | 0.48 | Par |
| Market Cap | 1.02B | - | Emerging |
